Abstract
The authors have withdrawn this manuscript (Genome-wide variations of SARS-CoV-2 infer evolution relationship and transmission route) from medRxiv, because it was found that the statistical and analytical methods used in the manuscript had certain controversies after further discussion, so the authors of the manuscipt disclaimed that this conclusion cannot be used as the basis for the origin and evolution of SARS-COV-2, also as information to guide clinical practice and health-related behaviors, it should not be reported as established facts in the news media and “We-Media”. No one should do too much extended interpretation of the content of this manuscript. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Shandong Province Science Foundation for Talent Cultivation [ZR2015PH059], the outstanding young technical backbone training project of Jinan [Shi-fu Wang], the State Major Infectious Disease Research Program [2012ZX10004206-007 and 2017zx10103004-007]. Lei Zhang is supported by the TaiShan Scholars Program of Shandong Province (No. tshw20120206) and TaiShan Industrial Experts Program (No. tscy20190612).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We downloaded a total of 188 complete genomes from GISAID, NCBI, the Global Coronavirus Data Sharing and Analysis System of the National Microbiology Data Center of China (http://nmdc.cn/coronavirus) and the 2019 Novel Coronavirus Resource (2019nCoVR) of the China National Center for Bioinformation (https://bigd.big.ac.cn/ncov/release_genome?lang=en)
